RR

Rashmi Rudragouda Patil

Active Director Director DIN 11807657
DIN 11807657 First appointment Jun 2026
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 2 active board seats
Total affiliations 2 Since Jun 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Rashmi Rudragouda Patil

Data last updated:

Rashmi Rudragouda Patil is a Director at Bridge Pharma Infinity Private Limited (since 2026) and Designated Partner at Astravion Pharmaceuticals Llp (since 2026).

DIN 11807657
Primary Designation Director
First Appointment 22 Jun 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director07 Jul 20262026Active
Designated Partner22 Jun 20262026Active

Directorship timeline

Open interactive timeline →
Astravion Pharmaceuticals Llp
Bridge Pharma Infinity Private Limited
Premium access

Shareholding and investment profile for Rashmi Rudragouda Patil

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rashmi Rudragouda Patil

Rashmi Rudragouda Patil currently holds 2 directorships: Bridge Pharma Infinity Private Limited (Director, since 07 Jul 2026); Astravion Pharmaceuticals Llp (Designated Partner, since 22 Jun 2026).

Rashmi Rudragouda Patil was first appointed on 22 Jun 2026 as Designated Partner at Astravion Pharmaceuticals Llp.

The current boards of Rashmi Rudragouda Patil's companies include Roopa (Bridge Pharma Infinity Private Limited), Bharatesh Kidambi (Bridge Pharma Infinity Private Limited), Medipalli Ambedkar Sastri (Bridge Pharma Infinity Private Limited), Nagaratna Shastrimath (Bridge Pharma Infinity Private Limited), Suma Mallikarjun Hulikantimath (Bridge Pharma Infinity Private Limited), Usha Kidambi (Bridge Pharma Infinity Private Limited), among others.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available